Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Clustering analysis in outpatients with allergic rhinitis in clinical practice.

Ciprandi G, Silvestri M, Pistorio A, Tosca MA, Cirillo I.

Allergy. 2018 Oct 26. doi: 10.1111/all.13645. [Epub ahead of print] No abstract available.

PMID:
30362571
2.

FEF25-75 and Asthma in Clinical Practice.

Ciprandi G, Gallo F, Cirillo I.

Iran J Allergy Asthma Immunol. 2018 Jun;17(3):295-297.

PMID:
29908548
3.

Impaired spirometry may predict bronchial hyperresponsiveness.

Cirillo I, Gallo F, Ciprandi G.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):2127-2129.e2. doi: 10.1016/j.jaip.2018.02.030. Epub 2018 Mar 17. No abstract available.

PMID:
29559209
4.

Could routine spirometry suggest sensitisation in the military medicine setting?

Cirillo I, Gallo F, Ciprandi G.

J R Army Med Corps. 2018 Feb;164(1):58-60. doi: 10.1136/jramc-2017-000841. Epub 2017 Nov 24.

PMID:
29176005
5.

Fractional Exhaled Nitric Oxide: A Potential Biomarker in Allergic Rhinitis?

Ciprandi G, Gallo F, Ricciardolo FL, Cirillo I.

Int Arch Allergy Immunol. 2017;172(2):99-105. doi: 10.1159/000456548. Epub 2017 Mar 3.

PMID:
28253520
6.

The asthma control in daily practice.

Ciprandi G, Tosca MA, Cirillo I, Gallo F, Ricciardolo FL, Sadatsafavi M, Mark FitzGerald J.

Allergy. 2016 Jun;71(6):907-9. doi: 10.1111/all.12893. No abstract available.

PMID:
27168014
7.

Safety and Tolerability of Doripenem in Hospitalized Children With Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections and Pneumonia.

Cannavino CR, Castaneda-Ruiz B, Redman R, Go O, Cirillo I, Barauskas V, Senatorova G, Emeryk A, Bradley JS.

Pediatr Infect Dis J. 2015 Nov;34(11):1264-7. doi: 10.1097/INF.0000000000000859.

PMID:
26226440
8.

Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological Age.

Cirillo I, Vaccaro N, Castaneda-Ruiz B, Redman R, Cossey V, Bradley JS, Allegaert K.

Antimicrob Agents Chemother. 2015 Aug;59(8):4742-9. doi: 10.1128/AAC.00485-15. Epub 2015 May 26.

9.

The relevance of obesity on asthma control in identical twins.

Ciprandi G, Cirillo I, Ricciardolo FL.

Allergol Int. 2015 Jan;64(1):104-5. doi: 10.1016/j.alit.2014.08.007. Epub 2014 Dec 17. No abstract available.

10.

Allergic rhinitis phenotypes based on bronchial hyperreactivity to methacholine.

Ciprandi G, Ricciardolo FL, Schiavetti I, Cirillo I.

Am J Rhinol Allergy. 2014 Nov-Dec;28(6):214-8. doi: 10.2500/ajra.2014.28.4124.

PMID:
25514477
11.

Increased body mass index and bronchial impairment in allergic rhinitis.

Ciprandi G, Ricciardolo FL, Signori A, Schiavetti I, Monardo M, Ferraro MR, Cirillo I.

Am J Rhinol Allergy. 2013 Nov-Dec;27(6):e195-201. doi: 10.2500/ajra.2013.27.3979.

PMID:
24274214
12.

Extending the record of bis-γ-pyrone polypropionates from marine pulmonate mollusks.

Carbone M, Ciavatta ML, Wang JR, Cirillo I, Mathieu V, Kiss R, Mollo E, Guo YW, Gavagnin M.

J Nat Prod. 2013 Nov 22;76(11):2065-73. doi: 10.1021/np400483c. Epub 2013 Nov 1.

PMID:
24180210
13.

Increased body mass index and bronchial impairment in allergic rhinitis.

Ciprandi G, Ricciardolo FLM, Signori A, Schiavetti I, Monardo M, Rosaria Ferraro M, Cirillo I.

Am J Rhinol Allergy. 2013 Nov 1;27(6):195-201. doi: 10.2500/ajra.2013.27.3979.

PMID:
29021073
14.

Methacholine bronchial challenge effects on nasal symptoms and function in patients with allergic rhinitis.

Cirillo I, Medusei G, Signori A, Ciprandi G.

Eur Ann Allergy Clin Immunol. 2013 Aug 1;45(4):123-9.

PMID:
24067337
15.

FEF25-75: a marker for small airways and asthma control.

Ciprandi G, Cirillo I, Pasotti F, Ricciardolo FL.

Ann Allergy Asthma Immunol. 2013 Sep;111(3):233. doi: 10.1016/j.anai.2013.06.012. Epub 2013 Jul 16. No abstract available.

PMID:
23987209
16.

FEF25-75 should be carefully considered in allergic rhinitis.

Ciprandi G, Cirillo I.

Allergol Immunopathol (Madr). 2013 May-Jun;41(3):211. doi: 10.1016/j.aller.2013.01.003. Epub 2013 Mar 26. No abstract available.

PMID:
23537593
17.

Impaired FEF25-75 may predict high exhaled nitric oxide values in children with allergic rhinitis and/or asthma.

Ciprandi G, Tosca MA, Cirillo I, Lionetti E, Leonardi S, Miraglia Del Giudice M, La Rosa M, Salpietro A, Capasso M, Marseglia GL.

J Biol Regul Homeost Agents. 2012 Jan-Mar;26(1 Suppl):S27-33.

PMID:
22691247
18.

Impaired FEF25-75 values may predict bronchial reversibility in allergic children with rhinitis or asthma.

Ciprandi G, Capasso M, Leonardi S, Lionetti E, La Rosa M, Salpietro C, Miraglia Del Giudice M, Cirillo I, Tosca M, Marseglia GL.

J Biol Regul Homeost Agents. 2012 Jan-Mar;26(1 Suppl):S19-25.

PMID:
22691246
19.

Impaired spirometry may suggest sensitization.

Ciprandi G, Salpietro A, Leonardi S, Tosca MA, Miraglia Del Giudice M, Salpietro C, La Rosa M, Cirillo I, Signori A, Marseglia GL.

J Biol Regul Homeost Agents. 2012 Jan-Mar;26(1 Suppl):S15-7.

PMID:
22691245
20.

A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia.

Kollef MH, Chastre J, Clavel M, Restrepo MI, Michiels B, Kaniga K, Cirillo I, Kimko H, Redman R.

Crit Care. 2012 Nov 13;16(6):R218. doi: 10.1186/cc11862.

Supplemental Content

Loading ...
Support Center